S.Biomedics Co., Ltd. (KOSDAQ:304360)

S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,484	1,410	4,066	6,131	9,188
Short-Term Investments	7,746	8,175	2,346	6,750	3,000
Trading Asset Securities	11,720	1,073	1,007	-	259.94
Cash & Short-Term Investments	23,950	10,658	7,419	12,881	12,448
Cash Growth	124.71%	43.66%	-42.41%	3.48%	-20.17%
Accounts Receivable	1,753	1,922	1,246	388.8	713.77
Other Receivables	206.19	198.83	204.02	67.26	65.95
Receivables	2,050	2,211	1,540	456.07	789.71
Inventory	2,325	2,369	1,570	763.73	707.72
Prepaid Expenses	404.79	336.37	426	174.46	254.73
Other Current Assets	542.39	126.94	245.98	66.43	121.3
Total Current Assets	29,272	15,700	11,201	14,342	14,322
Property, Plant & Equipment	4,475	4,962	2,765	3,051	3,357
Long-Term Investments	500	1,533	1,000	0.06	0.04
Other Intangible Assets	407.86	118.78	153.76	25.44	19.32
Long-Term Deferred Tax Assets	436.96	358.55	412.76	-	-
Other Long-Term Assets	9,509	9,275	8,825	377.05	366.79
Total Assets	44,601	31,947	24,358	17,796	18,065
Accounts Payable	186.75	479.48	416.17	36.31	505.44
Accrued Expenses	266.11	294.48	253.98	182.96	138.66
Short-Term Debt	1,841	3,547	5,807	1,916	3,231
Current Portion of Long-Term Debt	6,591	338.51	331.66	96.02	88.94
Current Portion of Leases	911.85	804.99	442.6	492.23	441.04
Current Income Taxes Payable	126.69	39.1	13.46	-	-
Current Unearned Revenue	4.17	4.32	4.28	7.53	7.58
Other Current Liabilities	1,843	2,144	4,562	1,444	2,350
Total Current Liabilities	11,770	7,652	11,831	4,175	6,763
Long-Term Debt	9,256	6,480	7,008	3,783	1,392
Long-Term Leases	182.49	824.86	206.79	520.66	449.83
Long-Term Unearned Revenue	2,046	2,050	2,054	2,058	2,062
Other Long-Term Liabilities	948.91	932.98	622.38	2,058	1,480
Total Liabilities	26,289	19,593	23,323	13,964	13,265
Common Stock	5,873	5,669	5,110	5,110	5,075
Additional Paid-In Capital	76,481	64,803	44,478	44,478	43,936
Retained Earnings	-74,983	-68,269	-57,759	-51,485	-45,844
Comprehensive Income & Other	4,494	4,809	4,393	4,408	2,649
Total Common Equity	11,865	7,011	-3,779	2,510	5,816
Minority Interest	6,447	5,343	4,814	1,321	-1,017
Shareholders' Equity	18,311	12,354	1,035	3,832	4,800
Total Liabilities & Equity	44,601	31,947	24,358	17,796	18,065
Total Debt	18,781	11,995	13,796	6,808	5,602
Net Cash (Debt)	5,168	-1,337	-6,377	6,073	6,846
Net Cash Growth	-	-	-	-11.29%	-38.18%
Net Cash Per Share	449.56	-122.33	-624.02	598.26	677.20
Filing Date Shares Outstanding	11.75	11.34	10.22	10.22	10.15
Total Common Shares Outstanding	11.75	11.34	10.22	10.22	10.15
Working Capital	17,502	8,048	-629.62	10,167	7,559
Book Value Per Share	1010.11	618.41	-369.73	245.64	573.05
Tangible Book Value	11,457	6,892	-3,932	2,485	5,797
Tangible Book Value Per Share	975.39	607.93	-384.77	243.15	571.15
Land	453.44	241.82	241.82	117.16	117.16
Buildings	902.12	558.2	558.2	349.29	349.29
Machinery	7,007	6,061	4,849	4,552	4,091
Construction In Progress	24	829.26	441.24	42.5	5.4

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.